Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
26 studies found for:    Microcephaly
Show Display Options
RSS Create an RSS feed from your search for:
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Zika and Microcephaly: Case-control Study
Condition: Microcephaly
Intervention: Other: Questionary
2 Recruiting Microcephaly Genetic Deficiency in Neural Progenitors
Condition: Microcephaly
3 Withdrawn Postnatal HCMV Infection in Very Preterm Infants. Implications, Morbidity, Growth and Neurodevelopmental Outcomes.
Conditions: Hearing Loss;   Mental Retardation;   Microcephaly;   Chorioretinitis
4 Recruiting Neurodevelopment Outcome of Newborns Exposed to Zika Virus (ZIKV) in Utero
Conditions: Microcephaly;   Mental Retardation
Intervention: Other: Symptomatic pregnant women with positive RT-PCR ZIKV in serum or urine, or a positive serologic test specific for ZIKV
5 Recruiting Fetal and Maternal Head Circumference During Pregnancy in Israeli Population
Conditions: Maternal-Fetal Relations;   Microcephaly
Intervention: Other: no intervention
6 Completed Evaluation of Patients With Unresolved Chromosome Abnormalities
Conditions: Abnormalities;   Failure to Thrive;   Mental Retardation;   Microcephaly
7 Recruiting Zika Virus Infection's Pregnancy Consequences in French Department of America
Condition: Incidence of ZIKV Infection on Fetus During the Pregnancy
8 Not yet recruiting Finding Genes With NGS Techniques in Whom Mutations Cause Neurological Diseases
Condition: Neurological Diseases
Intervention: Genetic: Genetic testing
9 Recruiting Zika Virus Infection's Neonatal and Pediatric Consequences in French Department of America
Condition: Zika Virus Infection on Fetus and Child During the Pregnancy
Interventions: Other: fundus examination;   Other: Head ultrasound
10 Completed
Has Results
Dietary Supplements for the Treatment of Angelman Syndrome
Conditions: Angelman Syndrome;   Nervous System Diseases
Interventions: Drug: Betaine;   Drug: Creatine;   Drug: Metafolin;   Drug: Vitamin B12
11 Completed
Has Results
TOBY (TOtal Body hYpothermia): a Study of Treatment for Perinatal Asphyxia
Conditions: Asphyxia Neonatorum;   Hypoxia;   Encephalopathy;   Seizures
Intervention: Procedure: Whole body mild induced hypothermia
12 Unknown  Efficacy Study of Hypothermia Plus Magnesium Sulphate(MgSO4) in the Management of Term and Near Term Babies With Hypoxic Ischemic Encephalopathy
Conditions: Severe Hypoxic Ischemic Encephalopathy;   Moderate Hypoxic Ischemic Encephalopathy
Interventions: Drug: Magnesium Sulphate;   Drug: Placebo
13 Recruiting A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Conditions: Congenital Cytomegalovirus Infection;   Maternal Cytomegalovirus Infection
Intervention: Drug: CMV hyperimmune globulin
14 Completed CoolCap Trial, Treatment of Perinatal Hypoxic-Ischemic Encephalopathy
Condition: Neonatal Hypoxic-Ischemic Encephalopathy (HIE)
Intervention: Device: Cool-Cap
15 Recruiting Hypothermia for Encephalopathy in Low and Middle-Income Countries Trial
Condition: Neonatal Encephalopathy
Intervention: Device: Whole body cooling (Tecotherm)
16 Recruiting Study of GLS-5700 in Dengue Virus Seropositive Adults
Conditions: Healthy;   Zika
Interventions: Biological: GLS-5700;   Biological: Placebo
17 Active, not recruiting Study of GLS-5700 in Healthy Volunteers
Condition: Healthy
Intervention: Biological: GLS-5700
18 Completed Bone Mineral Density in Adults With Hyperphenylalaninemia
Condition: Phenylketonurias
19 Recruiting Transfusion of Prematures Trial
Conditions: Infant, Newborn, Diseases;   Infant, Extremely Low Birth Weight;   Infant, Small for Gestational Age;   Bronchopulmonary Dysplasia (BPD);   Anemia
Interventions: Procedure: Liberal Cell Transfusion;   Procedure: Restricted red cell transfusion
20 Recruiting Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA085-00-VP, in Healthy Adults
Conditions: Prevention of Zika Infection;   Zika-Specific Immune Response
Intervention: Biological: VRC-ZKADNA085-00-VP

   Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results    Last Page
Indicates status has not been verified in more than two years